Comments

MiNK Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does MiNK Therapeutics (INKT) operate in?

MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

INKTNASDAQ

Logo brought to you by Benzinga Data

Perks Trade with Public

$64.17

56.44730.14%

At close: -

$51.20

-12.97-20.21%

After Hours: Jul 11, 7:59 PM EDT

MiNK Therapeutics (INKT) Forecast

News Earnings MiNK Therapeutics (INKT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

MiNK Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:INKT | Benzinga

Explore MiNK Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INKT.

Open	$21.07
Close	$64.17
Volume / Avg.	47.86M / 7.47K
Day Range	$20.20 - $76.00
52 Wk Range	0.68 - 13.79
Market Cap	$204.07M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	98
Short Interest	1.25%
Days to Cover	1

Recent News

Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge

Avi Kapoor

Why Is Nano-Cap MiNK Therapeutics Stock Gaining Over 400% On Friday?

MiNK Therapeutics shares jumped as new clinical data show durable remission in testicular cancer and tumor reduction in gastric cancer using its iNKT cell therapy, agenT-797, in combination with Opdivo.

Vandana Singh

Dow Dips Over 200 Points; Levi Strauss Posts Upbeat Earnings

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$21.07
Close	$64.17
Volume / Avg.	47.86M / 7.47K
Day Range	$20.20 - $76.00
52 Wk Range	0.68 - 13.79
Market Cap	$204.07M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	98
Short Interest	1.25%
Days to Cover	1

About MiNK Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, develo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MiNK Therapeutics (INKT) stock?

You can purchase shares of MiNK Therapeutics (NASDAQ:INKT) through any online brokerage.

View our list of the best stock brokerages

Who are MiNK Therapeutics (INKT) competitors?

Other companies in MiNK Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Coeptis Therapeutics (NASDAQ:COEP), FibroGen (NASDAQ:FGEN) and FibroBiologics (NASDAQ:FBLG).

What is the forecast, or price target, for MiNK Therapeutics (INKT) stock?

MiNK Therapeutics has a consensus price target of $14.00.

What is the current price for MiNK Therapeutics (INKT)?

The stock price for MiNK Therapeutics (NASDAQ: INKT) is $51.2 last updated July 11, 2025 at 7:59 PM EDT.

Does MiNK Therapeutics (INKT) pay a dividend?

There are no upcoming dividends for MiNK Therapeutics.

When is MiNK Therapeutics (NASDAQ:INKT) reporting earnings?

MiNK Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is MiNK Therapeutics (INKT) going to split?

There is no upcoming split for MiNK Therapeutics.

What sector and industry does MiNK Therapeutics (INKT) operate in?

MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.